MRGPRX2の活性化を阻害することによって,キチンとキトーサンの偽アレルギー反応への影響の評価

Tao Jia¹, Ruiqi Li¹, Chenkun Liu²

¹Department of Dermatology The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China.

Food science & nutrition

|September 3, 2025

まとめ

キチンとキトサンは,MRGPRX2受容体を通じたマスト細胞の活性化を阻害する. キトサンはより強い抑制効果を示し,MRGPRX2媒介の疾患の治療に潜在的に使用されることを示唆しています.

科学分野:

免疫学
生物化学

背景:

キチンとキトサンは,免疫調節性特性を有する,豊富で費用対効果の高いバイオ材料です.
マスト細胞 (MCs) は先天的な免疫とアレルギー反応において重要な役割を果たします.
マスに関連したGタンパク質結合受容体X2 (MRGPRX2) は,MCsで偽アレルギー反応と慢性疾患を媒介する.

研究の目的:

MRGPRX2媒介のMC活性化に対するキチンとキトサンの抑制効果を調査する.
MCの脱粒化と関連する炎症媒介体の放出を抑制するキチンとキトーサンの有効性を比較する.

主な方法:

インビトロMCデグラニュレーション試験
物質P (SP) 誘発の局所的受動性アナフィラキシーモデル
β-ヘクソサミナゼ,ヒスタミン,TNF-α,MCP-1,およびIL-8の放出量測定

主要な成果:

キチンとキトサンは,MRGPRX2媒介によるMC脱粒化をインビトロで抑制した.
チチンとキトサンは,β-ヘクソサミニダース,ヒスタミン,TNF-α,MCP-1,IL-8を含む炎症媒体の放出を減少させた.
この2つの化合物は,局所的な偽アレルギー反応を抑制し,微血管の拡張を vivo で減少させた.
チトサンはチチンよりも強い抑制効果を示した.

結論:

キチンとキトサンは,MRGPRX2媒介のマスト細胞活性化を効果的に抑制する.
キトサンは,MRGPRX2に関連する慢性疾患の管理のために,機能的な食品で優れた抑制力を示し,有益である可能性があります.

キーワード:

サイトカインデグラニュレーション炎症マスト細胞

さらに関連する動画

08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.5K

03:32

Measurement of Chitinase Activity in Biological Samples

Published on: August 22, 2019

10.4K

関連する概念動画

01:27

Allergic Drug Reactions

972

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...

972

01:25

Cholinergic Receptors: Muscarinic

2.9K

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....

Allergic Reactions

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

6.4K

01:24

Cholinergic Antagonists: Pharmacokinetics

558

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...

558

関連する実験動画